Healthcare Industry News: Inflammatory Bowel Disease
News Release - January 24, 2006
BIOSAFE Announces Instant Anemia Test for Medical ProfessionalsLAKE FOREST, IL--(Healthcare Sales & Marketing Network)--Jan 24, 2006 -- BIOSAFE Medical Technologies today announced the release of its new BIOSAFE Hemo-Quant(TM) rapid anemia test. This low cost, single use, disposable unit is for professional use by physicians and hospitals. It will be available to medical professionals beginning Q2 - 2006.
Designed and developed by BIOSAFE's research and development team to measure hemoglobin levels, this FDA approved and CLIA waived device provides a result in less than 10 minutes that is both easy to understand and as accurate as a standard laboratory analysis. The product will be available through major medical products' distributors and will be priced to support third-party reimbursement.
Hemoglobin is the red pigment in red blood cells that transports oxygen throughout the body. Anemia is a blood condition identified by a lower than normal number of red blood cells, usually measured by a decrease in the amount of hemoglobin. Risk factors for anemia include heavy menstrual periods, pregnancy and older age, as well as serious diseases that cause anemia such as chronic kidney disease, diabetes, heart disease, cancer, rheumatoid arthritis, Inflammatory Bowel Disease, and HIV.
"Our goal is to bring products to market that benefit both the healthcare professional and the consumer. The BIOSAFE family of products for anemia testing serves both the consumer with the BIOSAFE AnemiaProŽ and the BIOSAFE Anemia Meter(TM) and now the medical professional with the BIOSAFE Hemo-Quant(TM). The new BIOSAFE Hemo-Quant(TM) distinguishes itself by providing a quick, easy and reliable way for physicians and other healthcare professionals to test for anemia in their offices or non-clinical settings at a price that is consistent with current reimbursement guidelines," said BIOSAFE's Chief Science Officer, Jack Maggiore, PhD. "We're confident that by providing an accurate, convenient, and inexpensive means of anemia detection, many more of those at risk for this dangerous condition will be identified."
BIOSAFE Medical Technologies, Inc. is a world leader in the development of micro blood sample testing technology. Located in Chicago, Illinois, BIOSAFE Laboratories, Inc. is a subsidiary of BIOSAFE Medical Technologies, Inc., and develops, manufactures, and processes health monitoring and screening products for the diabetes, women's health, men's health, and heart health markets.
Source: BIOSAFE Medical Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.